RE:RE:RE:Noble...Thank you PennyWise. I sold at $2.90 and will buy back when reversal is confirmed - but like I posted weeks ago this selling pressure was predictable and my only regret is not selling earlier when I first sensed this would be the outcome. IMO there is a credibility issue here that started with 'lab delays' when it seems they really had no plans to release infill assays anyhow. Then the 6-month strategic saga which included the CEO implying more than once and completely unecessarily about imminent strategic investor - at one point stating there were multiple parties interested further implying a deal was imminent. IMO there is a clear pattern here of over-promising and under-delievring. IMO the flow-through financing - priced cheaper than the last - induced significant selling and that combined with shorts likely due to failure to secure strategic investor is why share price may still have lower to go. What is going to reverse undeniable downward trend over the next 3-4 weeks? I struggle to see any imminent material news.